Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Ipsen
M.D. Anderson Cancer Center
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
The Netherlands Cancer Institute
National Cancer Institute (NCI)
GlaxoSmithKline
Ocellaris Pharma, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Alpha Tau Medical LTD.
Blueprint Medicines Corporation
Transgene
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Novartis
Shasqi, Inc.
National Cancer Institute (NCI)
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Novartis
Novartis
3B Pharmaceuticals GmbH
Eli Lilly and Company
M.D. Anderson Cancer Center
Incyte Corporation
Washington University School of Medicine
Numab Therapeutics AG
Telix Pharmaceuticals (Innovations) Pty Limited
M.D. Anderson Cancer Center
Eli Lilly and Company
PTC Therapeutics
Shanghai Pharma Biotherapeutics USA Inc.
ADC Therapeutics S.A.
University of Kansas Medical Center
Hutchmed
M.D. Anderson Cancer Center
University of Washington
Elevation Oncology
IGM Biosciences, Inc.
Columbia University
Medical College of Wisconsin
Foghorn Therapeutics Inc.
Mayo Clinic
Oncternal Therapeutics, Inc
Alliance for Clinical Trials in Oncology